Immediate Impact
53 standout
Citing Papers
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Standout
Works of Ayako Hirai being referenced
Prognostic factors of advanced or postoperative recurrent non-small cell lung cancer targeted with immune check point inhibitors
2019
Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ayako Hirai | 211 | 205 | 84 | 51 | 455 | |
| So Jeong Lee | 119 | 193 | 123 | 50 | 424 | |
| Nobuhiko Kanaya | 113 | 220 | 86 | 54 | 463 | |
| Qian Zhao | 175 | 149 | 126 | 42 | 399 | |
| James B. Hayden | 263 | 177 | 100 | 30 | 474 | |
| Susumu Okano | 187 | 205 | 185 | 61 | 460 | |
| Takashi Sakai | 189 | 121 | 109 | 66 | 412 | |
| Matías Chacón | 180 | 179 | 97 | 55 | 406 | |
| Tianyi Fang | 162 | 230 | 110 | 36 | 439 | |
| Samuel Rosner | 134 | 242 | 72 | 33 | 392 | |
| Joshua E. Reuss | 241 | 354 | 50 | 52 | 494 |
All Works
Loading papers...